Friedhelm R Schuster
Overview
Explore the profile of Friedhelm R Schuster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
595
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cicek A, Schuster F, Boyle J, Hoenig M, Meisel R, Ghosh S
J Clin Immunol
. 2025 Feb;
45(1):74.
PMID: 39932644
Reticular dysgenesis (RD) is a rare inborn error of immune cell formation defined by severe combined immunodeficiency, agranulocytosis and sensorineural deafness. We report a case of successful haploidentical maternal hematopoietic...
2.
Flaadt T, Ladenstein R, Ebinger M, Lode H, Arnardottir H, Poetschger U, et al.
J Clin Oncol
. 2023 Feb;
41(17):3135-3148.
PMID: 36854071
Purpose: Patients with relapsed high-risk neuroblastoma (rHR-NB) have a poor prognosis. We hypothesized that graft-versus-neuroblastoma effects could be elicited by transplantation of haploidentical stem cells (haplo-SCT) exploiting cytotoxic functions of...
3.
Heinz A, Calkoen F, Derbich A, Miltner L, Seitz C, Doering M, et al.
Haematologica
. 2023 Feb;
108(8):2080-2090.
PMID: 36794500
Therapy-resistant viral reactivations contribute significantly to mortality after hematopoietic stem cell transplantation. Adoptive cellular therapy with virus-specific T cells (VST) has shown efficacy in various single-center trials. However, the scalability...
4.
Babor F, Peters C, Manser A, Glogova E, Sauer M, Potschger U, et al.
Bone Marrow Transplant
. 2019 May;
54(11):1847-1858.
PMID: 31089287
Although allogeneic hematopoietic stem-cell transplantation (HSCT) provides high cure rates for children with high-risk acute lymphoblastic leukaemia (ALL), relapses remain the main cause of treatment failure. Whereas donor killer cell...
5.
Gossling K, Fouz H, Kyrillopoulou O, Aubin M, Maecker-Kolhoff B, Adams O, et al.
Clin Infect Dis
. 2018 Oct;
68(8):1406-1409.
PMID: 30357314
Here, we report the case of severe adenoviremia in a 7-year-old boy with highly-resistant, acute leukemia. A combined approach of αβTCR-CD19-depleted stem cell transplantation, enabling immunosuppression-free post-transplant care, and early...
6.
Gossling K, Schipp C, Fischer U, Babor F, Koch G, Schuster F, et al.
Front Immunol
. 2017 Jul;
8:773.
PMID: 28713390
Immunodeficiency, centromeric instability, and facial anomaly (ICF) syndrome is a rare autosomal recessive genetic condition with severe immunodeficiency, which leads to lethal infections if not recognized and treated in early...
7.
Ghosh S, Honscheid A, Duckers G, Ginzel S, Gohlke H, Gombert M, et al.
Haematologica
. 2016 Dec;
102(2):e69-e72.
PMID: 27979922
No abstract available.
8.
Seidel U, Schlegel P, Grosse-Hovest L, Hofmann M, Aulwurm S, Pyz E, et al.
Mol Ther
. 2016 Jul;
24(9):1634-43.
PMID: 27380762
Prognosis of primary refractory and relapsed pediatric B-lineage acute lymphoblastic leukemia (ALL) is very poor. Relapse rates significantly correlate with persistent minimal residual disease (MRD). In MRD, favorable effector-target ratios...
9.
Feucht J, Opherk K, Lang P, Kayser S, Hartl L, Bethge W, et al.
Blood
. 2015 Jan;
125(12):1986-94.
PMID: 25617426
Hematopoietic stem cell transplantation (HSCT) has improved over the last few decades. However, viral infections are often refractory to pharmacologic treatment and require alternative treatment strategies such as immunotherapy. Adenovirus...
10.
Schuster F, Stanglmaier M, Woessmann W, Winkler B, Siepermann M, Meisel R, et al.
Br J Haematol
. 2014 Dec;
169(1):90-102.
PMID: 25495919
Children with B cell malignancies refractory to standard therapy are known to have a poor prognosis and very limited treatment options. Here, we report on the treatment and follow-up of...